FibroGen Inc (FGEN) Q3 2025 Earnings Call Highlights: Strategic Moves Bolster Financial ... [Yahoo! Finance]
FibroGen, Inc (FGEN)
Last fibrogen, inc earnings: 3/2 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
phx.corporate-ir.net/phoenix.zhtml?c=253783&p=irol-irhome
Company Research
Source: Yahoo! Finance
Total Operating Costs and Expenses: $6.5 million for Q3 2025, a decrease of 86% from $47.8 million in Q3 2024. R&D Expenses: $1.2 million for Q3 2025, down 94% from $20 million in Q3 2024. SG&A Expenses: $5.3 million for Q3 2025, a decrease of 43% from $9.4 million in Q3 2024. Net Loss from Continuing Operations: $13.1 million or $3.25 per share for Q3 2025, compared to $48.3 million or $12.01 per share in Q3 2024. Cash and Cash Equivalents: $121.1 million as of September 30, 2025. Cash Runway: Extended into 2028 following the sale of FibroGen China. FibroGen China Sale: Completed for approximately $220 million, including $135 million net cash held in China. Warning! GuruFocus has detected 5 Warning Signs with FGEN. Is FGEN fairly valued? Test your thesis with our free DCF calculator. Release Date: November 10, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript Positive Points FibroGen Inc ( NASDAQ:FGEN ) c
Show less
Read more
Impact Snapshot
Event Time:
FGEN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FGEN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FGEN alerts
High impacting FibroGen, Inc news events
Weekly update
A roundup of the hottest topics
FGEN
News
- FibroGen to Present at the Oppenheimer Movers in Rare Disease Summit [Yahoo! Finance]Yahoo! Finance
- FibroGen to Present at the Oppenheimer Movers in Rare Disease SummitGlobeNewswire
- FibroGen, Inc. (FGEN) Q3 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- FibroGen Reports Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]Yahoo! Finance
- FibroGen Reports Third Quarter 2025 Financial Results and Provides Business UpdateGlobeNewswire
FGEN
Earnings
- 11/10/25 - Beat
FGEN
Analyst Actions
- 9/24/25 - HC Wainwright
FGEN
Sec Filings
- 11/17/25 - Form 4
- 11/14/25 - Form SCHEDULE
- 11/10/25 - Form 10-Q
- FGEN's page on the SEC website